A full market analysis — including TAM/SAM/SOM breakdown, state-by-state regulatory map,
federal rescheduling scenario analysis, and competitive positioning — is being prepared.
Market overview is available in the Business Plan (Sections 03 and 07).
DEA rescheduling of cannabis from Schedule I to Schedule III is the most probable near-term federal action.
Any normalization significantly expands the addressable market — removing banking restrictions, reducing compliance
overhead for operators, and attracting institutional capital that currently avoids the sector.